Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
105.42
+5.12 (5.10%)
At close: Nov 21, 2025, 4:00 PM EST
106.55
+1.13 (1.07%)
After-hours: Nov 21, 2025, 7:59 PM EST
Guardant Health Market Cap
Guardant Health has a market cap or net worth of $13.29 billion as of November 21, 2025. Its market cap has increased by 325.23% in one year.
Market Cap
13.29B
Enterprise Value
14.03B
1-Year Change
325.23%
Ranking
Category
Stock Price
$105.42
Market Cap Chart
Since October 4, 2018, Guardant Health's market cap has increased from $2.69B to $13.29B, an increase of 393.85%. That is a compound annual growth rate of 25.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 13.29B | 252.02% |
| Dec 31, 2024 | 3.77B | 14.96% |
| Dec 29, 2023 | 3.28B | 17.84% |
| Dec 30, 2022 | 2.79B | -72.60% |
| Dec 31, 2021 | 10.17B | -21.09% |
| Dec 31, 2020 | 12.88B | 75.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |